Everything you need to build targeted LNPS.

With industry-leading technical capabilities and experts, Tiva Bio provides a wide range of products and services to support tLNP development in gene editing, in vivo CAR-T, and other groundbreaking therapies.

★ New · October 2025

Off-the-shelf catalogue.

Tiva is pleased to launch off-the-shelf products to accelerate targeted-LNP development — ready to ship, GMP-tested, and validated in vitro and in vivo.

Reporter mRNA

mRNA
eGFP mRNA 10001-10mg · Reporter
Purity≥96%
Integrity≥90%
Residual dsRNA<0.01%
Endotoxin<0.01 EU/mg

Tiva's reporter mRNA materials are manufactured and tested under GMP-compliant conditions, and have been used extensively in both in vitro and in vivo experiments.

Targeted LNP Materials

tLNP · Ref standard
CD8-eGFP-LNP 20001-1mg · Reference standard
Size<100 nm
PDI<0.15
Encapsulation>90%
Conjugation>80%
CD3-eGFP-LNP 20002-1mg · Reference standard
Size<100 nm
PDI<0.15
Encapsulation>90%
Conjugation>80%
Validation data

High conjugation, cell-specific transfection.

Tiva's CD8-eGFP-LNP shows a high percentage of conjugated LNP and a high degree of CD8-cell-specific transfection.

CD8⁺ T cells express GFP strongly, while CD4⁺ cells stay near baseline — confirming on-target delivery.

20 40 60 80 100 0 GFP⁺ (%) 74% 59% <1% CD8⁺ cells CD4⁺ cells
10 ng/well 100 ng/well

Kits & Reagents

Kit
Ready-to-target CD8 kit 30001 · Transform LNPs into CD8 tLNPs
Customer LNP
Customer LNP
your formulation
Tiva 30001 CD8αFab-PEG-lipid
Tiva 30001
CD8αFab-PEG-lipid
CD8 targeted LNP
CD8 tLNP
ready to target

Tiva's Ready-to-target CD8 kit is a high-affinity CD8α-binding Fab conjugated to a PEGylated lipid. Mixed with LNPs under defined conditions, the CD8αFab-PEG conjugate integrates into the lipid layer and transforms them into CD8-targeting tLNPs — so you can screen multiple targeting ligands at once using the same LNP batch.

Four capabilities, one delivery partner.

Targeted LNP Formulation

01
  • LNP formulation customized for a wide variety of cargos
  • LNP–ligand conjugation
  • GMP-ready process development
  • Manufacturing of high-quality tLNP product suitable for in vivo studies

tLNP Characterization

02
  • Encapsulation efficiency
  • Particle size and PDI
  • Ligand conjugation efficiency using LC/MS
  • Ligand density using nanoflow cytometry
  • Assay qualification

tLNP Services

03
  • Scaling up from 1 mg to above 500 mg of cargo
  • Tech transfer from development to GMP
  • Advisory and project management
  • Investigator-initiated trial support

Off-the-shelf Products

04
  • Reporter mRNA — eGFP, luciferase, CD20 CAR
  • Targeted LNP reference standards — CD3 & CD8 with eGFP or CD20 CAR
  • Ready-to-target kits
  • More products to come
→ Browse the catalogue

From a custom formulation through full characterization and GMP scale-up, Tiva supports your program at every stage — or ships ready-to-use products you can start with today.

Request the full catalogue & product information sheets.

Tell us about your cargo and the cells you need to reach. Our team will share pricing, lead times, and spec sheets, or scope a custom formulation with you.

ordering@tiva.bio
Send us a message